avelumab
pfizer,merck
['#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'javelin,bladder', 'javelin,100', 'bladder 100', 'mibc', 'javelin,bladder,100', 'gu ', 'bladder']
rounding out day 1 of gu with of , who expanded on long-term follow-up from the javelin bladder 100 trial, and interim pet-ct response to neoadjuvant chemotherapy in mibc. don't forget to tune in tomorrow for continued conference coverage! #gu23 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.